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Abstract: Chondroitin sulfate (CS) is a sulfated glycosaminoglycan (GAG) that is usually found attached to proteins as part of
a proteoglycan. The use of CS-based biomaterials in the field of tissue engineering applications has been intensively growing over
the past decades because CS is a biopolymer with the major advantages of being biodegradable, biocompatible, easily available, and
highly versatile. In vitro and in vivo studies have shown that CS-based biomaterials upregulate cartilage-specific gene expression in
chondrocytes and mesenchymal stem cells and also support osteogenic differentiation by increasing the effectiveness of bone anabolic
growth factors. Chondroitin sulfate proteoglycan plays a key role during the acute recovery stage after spinal cord injury by activating
microglia/macrophages and modulating neurotrophic factor secretion. In addition, CS-based materials promote the wound-healing
process and stimulate the regeneration of skin defects. Moreover, CS can be used to construct high toughness gels by having a double
network structure. Taken together, CS-based biomaterials would be a useful material for successful replacement and regeneration of
damaged cartilage, bone, skin, and neural tissues.
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1. Introduction
Tissue engineering, which aims to create scaffolding
materials for regenerating tissue equivalents of blood
vessels, heart muscle, nerves, cartilage, bone, and others
using the recruitment of native cells into the scaffold and
subsequent deposition of extracellular matrix (ECM),
requires the multidisciplinary principles of materials
science, medicine, and life science (Lee and Yuk, 2007; Lee
and Mooney, 2012; Pawar and Edgar, 2012). Biomaterials
play an essential role for regenerating defective tissues
by supporting and retaining cells structurally in the
defective area (Tan et al., 2007). The properties of
biomaterials should include biocompatibility, desired
mechanical strength, microstructure and degradation
rate, and capability to support cell residence and to
retain metabolic functions (Kharkar et al., 2013). Natural
polymers composed of ECM are highly potential building
blocks for preparing biomaterials for tissue engineering
because natural polymers have chemical versatility and
biological performance. Among the components of ECM,
glycosaminoglycans (GAGs) are complex polysaccharides
that play important roles in cell growth, differentiation,
morphogenesis, cell migration, and bacterial/viral
infections (Yamada et al., 2011). GAGs can be classified
as nonsulfated GAGs, such as hyaluronic acid (HA), and
* Correspondence: kwonhj@eulji.ac.kr
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sulfated GAGs, such as heparin sulfate, chondroitin sulfate,
dermatan sulfate, and keratin sulfate (Schnabelrauch et
al., 2013). GAG chains are attached to a central protein to
form the proteoglycans with the exception of HA. GAGs
are able to absorb large quantities of water due to their
polyelectrolyte nature and this osmotic swelling provides
compressive strength. Chondroitin sulfate (CS) is widely
distributed as one of the most physiologically important
GAGs in ECMs and at cell surfaces. CS has been found
to be involved in the signaling functions of various
growth factors and chemokines such as platelet-derived
growth factors (PDGFs), fibroblast growth factors (FGFs),
epidermal growth factors (EGFs), and transforming
growth factor betas (TGF-βs) (Fthenou et al., 2008; Sirko
et al., 2010; Hintze et al., 2012) and play critical roles in the
developmental processes (Knudson and Knudson, 2001;
Hwang et al., 2003; Laabs, 2005). CS also contributes to
stabilization of the active conformation of growth factors
by protecting them from fast degradation (Taipale and
Keski-Oja, 1997; Wang et al., 2008). CS plays important
roles in modulating the stability, activity, release, and
spatial localization of growth factors, which are closely
associated with the sulfation patterns of the CSs (Deepa
et al., 2002; Takagaki et al., 2002). Thus, CS has been
considered as a potential material for tissue engineering.
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However, since the water-soluble nature of CS limits its
application as a biomaterial, crosslinking treatment is
required for tailoring the properties of CS or combining it
with other stable polymers such as chitosan (CHS), gelatin
(Gel), and HA (Sintov et al., 1995; Park et al., 2000; Chang
et al., 2003; Fan et al., 2006; Flanagan et al., 2006; Wang et
al., 2007). This review focuses on the biological role of CS
and its application for tissue engineering. The application
of CS-based materials for repair and regeneration of
various tissues such as cartilage, bone, neural tissues, and
skin is summarized in this review.
2. Fundamental properties of chondroitin sulfate
CS is composed of repeating disaccharide unit polymers
of D-glucuronic acid and N-acetyl galactosamine
sulfated at either 4- or 6-positions (Figure 1). CS can be
classified as galactosaminoglycan because CS has the
characteristic disaccharide units of glucuronic acid and
N-acetylgalactosamine. CS is synthesized and sulfated
intracellularly, and then secreted extracellularly and
attached glycosidically to serine in core proteins through
the glucuronic acid–galactose–galactose–xylose to
produce proteoglycan such as aggrecan and versican
(Dick et al., 2012). The biosynthesis of chondroitin
sulfate proteoglycans (CSPGs) is a very complex process
that requires glycosyltransferases, glucuronyltransferase-I,
the chondroitin synthase family of enzymes, and
chondroitin polymerizing factor, broadly distributed
in tissues (Mikami and Kitagawa, 2013). In addition,
sulfotransferase catalyzes the transfer of a sulfate group
from 3’-phosphoadenosine 5’-phosphosulfate (PAPS)
to the sulfation sites on CS chains (Yamaguchi et al.,
2007). The sulfation pattern of CS chains is tightly linked
to their specific interactions with various bioactive
molecules, and thus CS chains differing in the degree
and profile of sulfation play distinct functions in cellular
adhesion, migration, proliferation, and differentiation by
modulating the binding of growth factors and cytokines,

and the suppression of proteases (Deepa et al., 2002;
Takagaki et al., 2002). For example, it was reported that
oversulfated CS inhibits cortical neuronal cell adhesion
by blocking the actions of midkine (Ueoka et al., 2000).
CS is a polyelectrolyte with strong negative charges. Thus,
CS readily interacts with proteins in the extracellular
matrix due to its negative charges. Moreover, due to its
polyelectrolyte nature, CS can be used to construct a tough
biopolymer hydrogel via its double network structure.
The tough double network gel can be constructed by two
interpenetrating networks that have contrasting physical
structures and properties (Gong, 2010). In the double
network gel, CS was used for creating a rigid network and
poly(N,N-dimethyl acrylamide) (PDMAAm) was used for
creating a soft and ductile network (Suekama et al., 2013).
CS-based hydrogel can be used to create biopolymer-based
tough hydrogels for biomedical applications.
3. Cartilage regeneration using chondroitin sulfatebased materials
It has been shown that CS induces the synthesis of
cartilage-specific markers, collagen, and proteoglycan
by stimulating the chondrocyte metabolism (Jerosch,
2011). CS also increases the production of HA in synovial
cells, which leads to improvement in the viscosity and
the synovial fluid levels (David-Raoudi et al., 2009).
Furthermore, CS stimulates chondrocyte proliferation. In
addition, CS inhibits leukocyte elastase and hyaluronidase,
which are highly expressed in the synovial fluid of
rheumatic disease patients. It was reported that CS
inhibits cartilage destruction processes and stimulates
the processes of cartilage formation (Huskisson, 2008).
These results indicate that CS-based biomaterials would
be useful for cartilage regeneration. However, since CS has
a readily water-soluble nature, it is usual to make CS-based
materials through crosslinking treatment or combination
with other polymers such as CHS, Gel, and HA. It was
shown that the combination of CS with HA and N-acetyl

Figure 1. Schematic images of chondroitin 4-sulfate (C4S) and chondroitin 6-sulfate (C6S). BKChem was used for drawing
the chemical structures.
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galactosamine increases the synthesis of HA, glucosamine,
and collagen-II and suppresses ECM degrading enzymes,
which induces regeneration of cartilage tissues (Henson
et al., 2012). In addition, CS and its combination with
glucosamine sulfate showed in vivo beneficial effects
on the osteoarthritis disease process by regulating the
balance of the extracellular cartilage matrix and reducing
inflammatory and catabolic factors (Martel-Pelletier et al.,
2010). It was also shown that the hydrogels of collagen/CS/
HA prepared via two simultaneous processes of collagen
self-assembly and cross linking polymerization of CS–
methacrylate and HA–methacrylate upregulate cartilagespecific gene expression and promote the secretion of
GAG and collagen II in the chondrocytes (Guo et al.,
2012). In addition, the polysaccharide backbone of CS
can be chemically functionalized with methacrylate
and aldehyde groups, which can be linked to biological
proteins. In vitro and in vivo studies showed that CS led
to mechanical stability of the hydrogel and tissue repair in
cartilage defects (Wang et al., 2007). It was also reported
that fiber-reinforced hydrogels based on CS developed by
electrospinning technique induce enhancement of cartilage
specific extracellular matrix production in mesenchymal
stem cells (MSCs) (Coburn et al., 2011). Recently,
hydrogel made of synthetic sulfonated polyelectrolytes like
CS promoted chondrogenesis (Kwon et al., 2010; Kwon
and Yasuda, 2013). The sulfonated hydrogel increased
mRNA expression levels of type II collagen (COL2A1) and
aggrecan (AGC) by ~12-fold and ~17-fold, respectively,
even in the absence of any exogenous growth factors
(Figure 2a). Immunostaining and alcian blue staining also
showed that the sulfonated hydrogels increased expression
levels in type II collagen and GAG (Figures 2b and 2c).
4. Bone regeneration using chondroitin sulfate-based
materials
CS increases the regeneration ability of injured bone. CS
supports osteogenic differentiation of MSCs by increasing
the effectiveness of bone anabolic growth factors due to
the binding and presentation of the growth factor or by
modulating its signal transduction pathway (Büttner et
al., 2013). The CS–collagen-based BMP delivery system
showed high biocompatibility and osteogenic stimulation
(Keskin et al., 2005). In addition, it was demonstrated that
nanoparticles (NPs) based on the electrostatic interaction
between CHS and CS (CHS-CS NPs) can be uptaken
by human adipose-derived stem cells and the release
of platelet lysates (PLs) from CHS–CS NPs proved to
be effective for the enhancement of in vitro osteogenic
differentiation (Santo et al., 2012). It was also shown that
CS–bioglass composite (CS–BG) encapsulating bone
marrow cells can form a mechanically stable construct and
moreover induce bone regeneration in vivo, in cooperation
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with BMPs (Yang et al., 2015). Figure 3a shows that either
BG–CS or BG–CS containing BMPs (BG–CS–BM)
induced formation of the newly developed bone in greater
amounts, as compared to either the empty control or BGonly treatment. After 6 weeks of implantation, both BG–
2CS and BG–2CS–10BM showed a significant increase in
bone formation (~15% increase) as compared to either the
empty control (~1% increase) or BG-only treatment (~5%
increase) (Figure 3b).
5. Neural regeneration using chondroitin sulfate-based
materials
Chondroitin sulfate proteoglycans (CSPGs) are enriched
in the growth environment of neural stem cells (NSCs)
and are essential for FGF-2-mediated proliferation
and maintenance of neuron-generating neural stem/
progenitor cells (Sirko et al., 2007). Simultaneously, CS
plays inhibitory functions for maturation, migration,
and gliogenesis of neural stem/progenitor cell and that
the loss of function of CSPGs induced differentiation
and migration of neural progenitor cells (Gu et al., 2009;
Sirko et al., 2010). Therefore, CSPG is considered to be a
major obstacle for central nervous system (CNS) recovery
after injury and thus its degradation has become a key
therapeutic goal for CNS regeneration. Indeed, it was
demonstrated that some CSPGs such as aggrecan, versican,
and neurocan are related to brain disorders, schizophrenia,
and attention deficit hyperactivity disorder (Avram et al.,
2014). However, it was found that CSPG is abundantly
synthesized in response to CNS injury and thus plays a
key role during the acute recovery stage after spinal cord
injury by directly activating microglia/macrophages via
the CD44 receptor and modulating neurotrophic factor
secretion (Rolls et al., 2008). Due to the two faces of CSPG
in CNS repair, there has been little interest in developing
CS-based materials for CNS regeneration. However, CSbased materials have been reported to be beneficial for
peripheral nervous system (PNS) regeneration. It was
reported that hydrogels of thiolated CS crosslinked with
poly(ethylene glycol)-diacrylate can support robust
growth of nerve roots in vitro (Conovaloff et al., 2011).
In addition, the poly-DL-lactide (PDLLA) coated with CS
and CHS by the layer-by-layer electrostatic self-assembly
method (PDLLA/CHS/CS) onto which nerve growth
factor (NGF) was immobilized was used as the nerve
conduits (Xu et al., 2011). When the nerve conduits were
employed to bridge the 10-mm defects in the sciatic nerve
of the rats, a rapid functional recovery for the disrupted
nerves was observed (Figure 4a). The nerve conduction
velocities (NCVs) of the PDLLA/CHS/CS/NGF group and
the PDLLA/CHS/CS group were more than 60 m/s and
more than 50 m/s, respectively, which were significantly
faster than the PDLLA group (less than 40 m/s) and
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Figure 2. Expression of chondrogenic markers in prechondrogenic cells cultured on hydrogels with various charge density. (a) Gene expression analysis of type I collagen, aggrecan,
and type II collagen in ATDC5 cells cultured on various substrata: polystyrene dish (PS),
PDMAAm gel, P(AMPS-co-DMAAm) (molar fraction of AMPS, F = 0.5, 0.75) and poly2-acrylamido-2-methylpropanesulfonic acid (PAMPS) gel, in the absence of insulin at day 7
(gray bars) and day 14 (black bars). Expression of each gene was measured by quantitative real-time PCR and normalized to GAPDH expression levels. Values are means ± SD obtained in
four experiments. *P < 0.05 and **P < 0.01 vs. polystyrene, by Dunnett’s test. (b) Expression
of type II collagen was analyzed by immunofluorescent staining at 14 days of culture. The cells
were stained with an anti-type II collagen antibody (green) and Hoechst 33258 (red). Polystryrene dish (PS) and PAMPS gel, in the absence of insulin. Scale bar, 100 µm. (c) Expression
of proteoglycan was analyzed by alcian blue staining at 14 days of culture. Polystryrene dish
(PS) and PAMPS gel, in the absence of insulin. Scale bar, 100 µm. Reproduced with permission from H. J. Kwon et al., Acta Biomaterialia, 6, 494 (2010) © 2010, Elsevier, Inc.

furthermore there was no significant difference between
the PDLLA/CHS/CS/NGF group and the autograft control
group (Figure 4b). CS-based nerve conduits would be
expected to be useful materials for repairing nerve damage
and promoting the regeneration of peripheral nerve defect.

6. Skin regeneration using chondroitin sulfate-based
materials
Permanent wound recovery demands grafting of
autologous epithelium for restoring the epidermal function
of the skin. However, the treatment of extensively and
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Figure 3. (a) Histology sections from rabbit femoral defect after implantation for 4 weeks (I–IV) and 6 weeks (V–VIII):
empty control (I, V), BG-only (II, VI), BG-CS (III, VII), and BG-CS-BM (IV, VIII). Mineralized tissue was stained red and
nonmineralized soft tissue and cells were stained blue. An inset in (VI) shows a mineralized tissue observed adjacent to the host
bone. Scale: 600 µm. (b) Percentages of new bone formation for two bioglass-based composites in comparison to BG-only and
empty (EMT) controls after 4- and 6-week implantation. * P < 0.05, ** P < 0.01, and *** P < 0.001. Reproduced with permission
from S. Yang et al. J. Biomed. Mater. Res. A., 103, 235 (2015) © 2015, John Wiley & Sons, Inc.

deeply burned patients has been difficult due to the limited
number of donor sites available for autografting (Robson
et al., 1992; Loss et al., 2000). Thus, alternatives to autograft
have been developed to replace the skin component
(Burke et al., 1981). A bilayer CS–Gel–HA complex with
two layers was developed to play a role as the scaffold for
skin tissue engineering (Wang et al., 2006). The lower layer
of the membrane would be seeded with dermal fibroblasts
for dermis development and also plays a role as the feeder
layer for keratinocytes inoculation. The upper layer was
seeded with keratinocytes for epidermalization. After
being cultured in the air-liquid interface for 3 weeks, the
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keratinocytes differentiated into the stratified squamous
epithelium of normal skin tissues, which indicates that this
engineered skin equivalent was well formed, comparable
to other cultured skin substitutes. Moreover, when these
CS–Gel–HA complexes seeded with or without dermal
cells such as keratinocyte and fibroblasts were grafted
onto full thickness wounds in mice, the complexes showed
positive effect on promoting wound-healing process and
could be used to help the regeneration on the skin defect
(Wang et al., 2006). Collagen/CS/HA scaffolds were also
applied to dermal tissue engineering (Wang et al., 2010).
Morphological observation showed that the cross-linked
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Figure 4. (a) Digital photo images of nerve conduits and regenerated nerves of each group after implantation for
3 months, group I: CS/PDLLA/CHS/NGF, group II: CS/PDLLA/CHS, group III: PDLLA alone. (b) Nerve conduction
velocities (NCVs) of group A, B, C, and D 3 and 6 months after implantation in rats compared with each other (n = 6, * P
< 0.05). A: PDLLA/Chondroitin sulfate/Chitosan/NGF, B: PDLLA/Chondroitin sulfate/Chitosan, C: PDLLA, D: autograft
nerve. Reproduced with permission from H. Xu et al., Biomaterials, 32, 4506 (2011) © 2011, Elsevier, Inc.

collagen–CS–HA 9:1:1 scaffold had more degradationresistant and higher elastic modulus than other scaffolds
and more strongly promoted cellular adhesion and
proliferation, in comparison with the scaffolds with other
ratios (5:1:1 and 3:1:1). Moreover, an implantation study
showed that the cross-linked collagen–CS–HA scaffold
could more successfully repair full thickness skin defects
in vivo. In addition, silk fibroin (SF)/CS/HA ternary
scaffolds were constructed by freeze-drying for dermal
tissue engineering (Yan et al., 2013). The incorporation of
CS and HA with the SF solution increased cell adhesion,
survival, and proliferation. When SF, SF/HA, and SF/CS/
HA scaffolds were implanted onto dorsal full-thickness
wounds of rats, the SF/CS/HA scaffolds promoted dermis
regeneration compared to SF and SF/HA scaffolds and
improved angiogenesis and collagen deposition, which

indicating that CS stimulated dermal regeneration (Figure
5a). The tissue regeneration ratio of SF/CS/HA scaffolds
was more than 80%, which was significantly higher than
that of the SF/HA and SF scaffolds at each time point (P <
0.05) (Figure 5b). Furthermore, when vascular endothelial
growth factor (VEGF), platelet-derived growth factor
(PDGF), and basic fibroblast growth factor (bFGF)
expression in the SF/CS/HA groups were investigated
by immunohistochemistry, it was demonstrated that
the stimulation of secretion of VEGF, PDGF, and bFGF
and accumulation of these growth factors were related
to the induction of dermal regeneration. Likewise, CS
nanoparticle/chitin/poly(butylene succinate) composite
increased attachment and proliferation of dermal
fibroblasts, which indicates that the CS incorporated
composite is a suitable scaffold for skin tissue engineering
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Time (weeks)

Figure 5. (a) Macroscopic observations of skin wounds after implanting SF, SF/HA, and SF/CS/
HA scaffolds for 1, 2, 3, and 4 weeks; scale bar = 10 mm. (b) Tissue regeneration ratio and scaffold
degradation ratio at different time points in vivo (* P < 0.05). Reproduced with permission from
S. Yan et al. Acta Biomaterialia, 9, 6771 (2013) © 2013, Elsevier, Inc.

(Deepthi et al., 2014). In addition, CS–Gel–HA seeded
with genetically modified hair follicle stem cells promoted
angiogenesis during wound healing and facilitation
of vascularization in skin substitutes (Quan et al.,
2014). Therefore, CS-based scaffolds provide potential
for dermal tissue regeneration and could be used as a
skin tissue model for in vitro toxicology, physiology
examination, and in vivo wound healing in the near future.
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7. Conclusion
Since a loss of biological tissues has resulted in the functional
impairment and cosmetic deformation of patients, tissue
engineering is a growing field of interest in aged society.
CS has crucial functions as an ECM component in
growth factor signaling, wound healing, infection, tissue
morphogenesis, hemostasis, inflammation, and cell division
in vivo. Therefore, CS-based materials that mimic many
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roles of ECM found in tissues are promising biomaterials
for regenerative medicine. In spite of the high potential of
CS for tissue engineering, various significant challenges are
still associated with the use of CS-based biomaterials in
clinical applications. Some of these challenges include the
quality difference due to separation from living organisms,
low thermal resistance, rapid degradation upon contact
with body fluids or medium, weak mechanical properties,
and poor tunability, in comparison with synthetic
polymers. However, recent technological advancements
have overcome the disadvantages associated with CS-based
biomaterial for biomedical applications. For example, CSbased hydrogel can have high toughness by incorporating a

double network structure into the gel (Suekama et al., 2013).
The enhanced appreciation of the fundamental properties
and biological behavior of CS-based biomaterials, coupled
with growing knowledge in the areas of biochemistry,
molecular biology, and bioengineering, will lead to the
development of methods to optimize their performance
and their clinical utility.
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